Arcturus therapeutics to report second quarter financial results and provide corporate update on august 5, 2024

San diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a global messenger rna medicines company focused on the development of infectious disease vaccines and medicines to treat unmet medical needs within liver and respiratory rare diseases, today announced that it will release its financial results for the quarter ended june 30, 2024 after the market close on monday, august 5 and will also host a conference call and webcast at 4:30 pm eastern.
ARCT Ratings Summary
ARCT Quant Ranking